Investigating the clinical utility of plasma succinate with insights from an Sdhb -deficient murine model
Endocrine-Related Cancer · 2026
DOI: 10.1530/erc-26-0323 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine-Related Cancer, 2026. Verfasst von Yasemin C Cole und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genomic Medicine, University of Cambridge, Cambridge Biomedical Campus , Cambridge, UK. Hauptthemen laut MEDLINE: Succinate Dehydrogenase, Succinic Acid. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The succinate dehydrogenase (SDH) enzyme, composed of four subunits (A–D), has a key role in the Krebs cycle and oxidative phosphorylation. Germline pathogenic variants (GPVs) in the genes encoding the four subunits of the succinate dehydrogenase (SDH) enzyme (SDHA/SDHB/SDHC/SDHD), collectively known as SDHx, are recognized as a paradigm for the role of disordered metabolism in oncogenesis as GPVs in SDHx lead to a truncated citric acid cycle due to reduced or absent function of the SDH enzyme and accumulation of the oncometabolite succinate. GPVs in SDHx are the most common cause of hereditary PPGL and are associated with a higher risk of malignant PPGL and predispose to other tumors including renal cell carcinoma, gastrointestinal stromal tumors (GIST), and pituitary adenomas. Utilizing the linkage of SDHx to metabolic dysfunction, we performed prospective plasma metabolomics and identified succinate as a biomarker for early diagnosis of an underlying SDHx variant. Succinate reflected SDHx deficiency in individuals with germline predisposition and a small number of patients with somatic SDHx deficiency, and succinate levels correlated with tumor burden. Longitudinal sampling of patients illustrated that serial succinate measurements might be used as a biomarker for disease surveillance. These findings were validated by tissue analysis in a mouse model of Sdhb deficiency, where elevated succinate was observed in adrenal glands. While circulating plasma levels did not mirror the human cohort, this discrepancy suggests specific cellular thresholds for succinate or SDHx deficiency in adrenal gland tissue and highlights species-specific metabolic regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genomic Medicine, University of Cambridge, Cambridge Biomedical Campus , Cambridge, UK.
- Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health , Bethesda, Maryland, USA.
- Technion Integrated Cancer Center, Israel Institute of Technology , Haifa, Israel.
- Department of Endocrinology, Cambridge University Hospital, Cambridge Biomedical Research Centre, Addenbrooke's Hospital , Cambridge, UK.
- Protein Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc. , Frederick, Maryland, USA.
- Laboratory for Integrative Cancer Immunology, National Cancer Institute, National Institutes of Health , Bethesda, Maryland, USA.
ORCID-Profile: Yasemin C Cole, Ruth T Casey
Zitieren
APA
Cole, Y. C., Abramovich, I., Fernandez-Garcia, J., Docquier, F., MacFarlane, J., Xu, X., Andresson, T., Indig, I., Wang, H., Krishnan, A., Chen, S., Challis, B., Gottlieb, E., Zhuang, Z., Maher, E. R., & Casey, R. T. (2026). Investigating the clinical utility of plasma succinate with insights from an Sdhb -deficient murine model. Endocrine-Related Cancer. https://doi.org/10.1530/erc-26-0323
Vancouver
Cole YC, Abramovich I, Fernandez-Garcia J, Docquier F, MacFarlane J, Xu X, et al. Investigating the clinical utility of plasma succinate with insights from an Sdhb -deficient murine model. Endocrine-Related Cancer. 2026. doi:10.1530/erc-26-0323
BibTeX
@article{Cole2026,
author = {Cole, Yasemin C and Abramovich, Ifat and Fernandez-Garcia, Jonatan and Docquier, France and MacFarlane, James and Xu, Xia and Andresson, Thorkell and Indig, Iris and Wang, Herui and Krishnan, Anagha and Chen, Shuran and Challis, Ben and Gottlieb, Eyal and Zhuang, Zhengping and Maher, Eamonn R and Casey, Ruth T},
title = {Investigating the clinical utility of plasma succinate with insights from an Sdhb -deficient murine model},
journal = {Endocrine-Related Cancer},
year = {2026},
doi = {10.1530/erc-26-0323}
}
EUVIMED